REPLIGEN CORP Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPLIGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REPLIGEN CORP for March 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 59.05 | 1,009 | 59,581 | 20,534 | 21.5 K to 20.5 K (-4.68 %) |
| Mar 27 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 58.45 | 5,458 | 319,020 | 21,543 | 27 K to 21.5 K (-20.21 %) |
| Mar 20 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 60.91 | 500 | 30,457 | 215,107 | 215.6 K to 215.1 K (-0.23 %) |
| Mar 20 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 60.45 | 4,009 | 242,363 | 215,607 | 219.6 K to 215.6 K (-1.83 %) |
| Mar 20 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 59.24 | 10,041 | 594,813 | 219,616 | 229.7 K to 219.6 K (-4.37 %) |
| Mar 05 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 58.50 | 13,000 | 760,500 | 229,657 | 242.7 K to 229.7 K (-5.36 %) |
| Mar 05 2019 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 58.53 | 2,240 | 131,107 | 18,803 | 21 K to 18.8 K (-10.64 %) |
| Mar 05 2019 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Grant | A | 0.00 | 4,700 | 0 | 21,043 | 16.3 K to 21 K (+28.76 %) |
| Mar 05 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 58.52 | 2,645 | 154,785 | 27,001 | 29.6 K to 27 K (-8.92 %) |
| Mar 05 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 4,700 | 0 | 29,646 | 24.9 K to 29.6 K (+18.84 %) |
| Mar 04 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 59.52 | 5,653 | 336,467 | 5,653 | |
| Mar 04 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 58.88 | 1,875 | 110,400 | 24,946 | 26.8 K to 24.9 K (-6.99 %) |
| Mar 04 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 5,922 | 0 | 26,821 | 20.9 K to 26.8 K (+28.34 %) |
| Mar 04 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Option Exercise | A | 59.52 | 21,651 | 1,288,668 | 21,651 | |
| Mar 04 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 59.01 | 7,475 | 441,100 | 242,657 | 250.1 K to 242.7 K (-2.99 %) |
| Mar 04 2019 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Grant | A | 0.00 | 22,681 | 0 | 250,132 | 227.5 K to 250.1 K (+9.97 %) |
| Mar 04 2019 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Option Exercise | A | 59.52 | 4,042 | 240,580 | 4,042 | |
| Mar 04 2019 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 59.16 | 185 | 10,945 | 16,343 | 16.5 K to 16.3 K (-1.12 %) |
| Mar 04 2019 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Grant | A | 0.00 | 4,234 | 0 | 16,528 | 12.3 K to 16.5 K (+34.44 %) |